S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium
Status:
Terminated
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as FR901228 (depsipeptide), work in different
ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: This phase II trial is studying how well FR901228 works in treating patients with
advanced cancer of the urothelium that has progressed or recurred after receiving one
chemotherapy regimen.